Marksans Pharma Gets USFDA Approval for Generic Allergic Rhinitis Treatment
November 22, 2024 17:30
Marksans Pharma receives USFDA approval for its generic version of Loratadine tablets, a treatment for allergic rhinitis. The approval marks a significant milestone for the company.